Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with O / Oxyphenbutazone
 
Oxyphenbutazone
 

Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
BrandsAradinum
Artroflog
Butaflogin
Butanora
Butanova
Butapirone
Butazonic
Butilene
Californit
Cinophen-n
Crovaril
Deflogin
Etrozolidina
Flamaril
Flanaril
Flegmostam
Flogal
Floghene
Flogistin
Flogitolo
Flogodin
Flogoril
Flogostop
Flopirina
Frabel
Genal
Idrobutazina
Infamil
Infammil
Ipabutona
Iridil
Isobutazina
Isobutil
Metabolite I
Mysite
Neo-farmadol
Neofen
Offitril
Optimal
Oxalid
Oxazolidin
Oxazolidin-geigy
Oxazolioin
Oxi-fenibutol
Oxibutol
Oxybuton
Oxyphentamin
Pirabutina
Piraflogin
Poliflogil
Portoril
Rapostan
Remazin
Reumox
Reunabutal
Rumapax
Tandacote
Tandalgesic
Tandearil
Tanderal
Tanderil
Telidac
Telidal
Tendearil
Valioil
Visubutina
CategoriesPhospholipase A2 Vrv-Pl-Viiia inhibitor
ManufacturersWatson laboratories inc
Novartis pharmaceuticals corp
Synonyms1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione
1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl
4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine
4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione
Hydroxyphenylbutazon
OPB
Ossifenbutazone [dcit]
Oxifenbutazona [inn-spanish]
Oxifenylbutazon
Oxiphenbutazone
Oxiphenbutazonum
Oxyphenbutazonum [inn-latin]
Oxyphenobutazone
Oxyphenylbutazone
P-hydroxyphenylbutazone
P-oxyphenylbutazone
Usaf Ge-14

drug interactions

Acenocoumarol: The NSAID, oxyphenbutazone, may increase the anticoagulant effect of acenocoumarol.

Alendronate: Increased risk of gastric toxicity

Anisindione: The NSAID, oxyphenbutazone, may increase the anticoagulant effect of anisindione.

Dicumarol: The NSAID, oxyphenbutazone, may increase the anticoagulant effect of dicumarol.

Ethotoin: The NSAID, oxyphenbutazone, may increase the hydantoin effect of ethotoin.

Fosphenytoin: The NSAID, oxphenbutazone, may increase the hydantoin effect of fosphenytoin.

Mephenytoin: The NSAID, oxyphenbutazone, may increase the hydantoin effect of mephenytoin.

Phenytoin: The NSAID, oxphenbutazone, may increase the therapeutic and adverse effects of phenytoin.

Warfarin: The NSAID, oxyphenbutazone, may increase the anticoagulant effect of warfarin.